Drosophila Keap1 Condensates Under Oxidative Stress

The Keap1–Nrf2 pathway is widely recognized as a cytoplasmic stress-response system: Keap1 promotes Nrf2 degradation under basal conditions, whereas oxidative stress permits Nrf2 accumulation and activation of antioxidant and detoxification genes. The reference study, Drosophila Keap1 Proteins Assemble Nuclear Condensates in Response to Oxidative Stress, expands this framework by examining what happens to Drosophila Keap1, or dKeap1, after it enters the nucleus.

Its central contribution is mechanistic rather than merely descriptive. The authors connect stress-dependent nuclear localization with the formation of relatively immobile protein assemblies and then use domain deletions, fusion constructs, fluorescence recovery after photobleaching, and in vitro assays to identify sequence features that promote or restrain assembly. These results are relevant to researchers studying oxidative signaling, chromatin regulation, developmental transcription, and biomolecular condensates.

Study Background and Research Question

Keap1 and its transcriptional partner Nrf2, called dKeap1 and CncC in Drosophila, coordinate responses to oxidative and xenobiotic stress. In the canonical model, cytoplasmic Keap1 targets Nrf2 for ubiquitin-dependent proteasomal degradation. Stress disrupts that interaction, allowing newly synthesized Nrf2 to enter the nucleus and activate protective genes. However, both mammalian Keap1 and dKeap1 have also been observed in the nucleus.

Previous work cited by the authors indicated that dKeap1 binds chromatin, participates in developmental transcription, associates with ecdysone-responsive regions, and interacts genetically and physically with the nuclear lamina. These observations raise a broader question: does nuclear dKeap1 have an organized molecular state that could help regulate chromatin or transcription? The study addresses this question by testing whether oxidative stress induces dKeap1 assemblies resembling biomolecular condensates and by determining which regions of the protein control that behavior.

Key Innovation from the Reference Study

From nuclear localization to regulated assembly

The important conceptual advance is the shift from treating nuclear dKeap1 as a diffusely localized transcriptional regulator to considering it as a stress-responsive organizer of nuclear material. According to the reference study, dKeap1 gradually assembled nuclear foci after oxidative treatment, and fluorescence recovery after photobleaching showed reduced mobility within these structures. The observations suggest that stress changes not only where dKeap1 is located, but also how it is physically organized.

The work further identifies a division of labor among dKeap1 domains. Both the N-terminal domain and the C-terminal domain were required for nuclear focus formation. The authors also identified two intrinsically disordered regions within the C-terminal domain and found that C-terminal fluorescent fusion proteins readily formed condensates in vitro. In contrast, removal of the Kelch domain produced strong cytoplasmic foci even without stress, while in vitro results indicated that the Kelch domain suppresses dKeap1 condensate formation.

This combination of positive and negative regulatory elements is a significant innovation. It suggests that dKeap1 assembly is not simply caused by an intrinsically disordered tail acting independently. Instead, condensate behavior may emerge from regulated interactions among structured domains, disordered regions, cellular localization, and stress-dependent context.

Methods and Experimental Design Insights

The experimental design combined cellular imaging with reductionist biochemical analysis. Drosophila stocks and fluorescently labeled dKeap1 constructs were used to compare protein distribution before and after oxidative treatment. Live fluorescence imaging allowed the investigators to follow the gradual appearance of nuclear foci rather than relying only on fixed-cell snapshots.

FRAP provided a functional measurement of material mobility. A fluorescent region within a dKeap1 focus was photobleached, and recovery was monitored over time. Reduced recovery is consistent with a less mobile molecular population, although FRAP alone does not establish a particular phase state. The study therefore strengthened the interpretation by testing isolated protein regions in vitro.

Domain analysis was central to the design. Full-length dKeap1 was compared with constructs containing or lacking the N-terminal, C-terminal, or Kelch regions. The C-terminal domain was fused to YFP for in vitro condensate assays, while Kelch-domain deletion constructs were used to test whether this structured region restrains assembly. This approach distinguishes regions that are necessary for assembly from regions that can autonomously promote condensation when isolated.

Protocol Parameters

• Stress comparison: Compare untreated and oxidative-treatment conditions using matched expression and imaging settings; the reference study supports a stress-dependent increase in nuclear dKeap1 foci, but exact treatment details should be taken from its full Methods section.
• Live imaging: Follow dKeap1 localization over time and record both nuclear accumulation and focus development rather than scoring only endpoint presence or absence.
• Mobility analysis: Use FRAP or a comparable recovery assay to distinguish bright fluorescence from reduced molecular mobility; recovery kinetics should be interpreted alongside focus morphology.
• Domain testing: Analyze full-length protein, N-terminal and C-terminal constructs, and Kelch-deletion variants in parallel so that assembly-promoting and assembly-suppressing effects can be separated.
• In vitro validation: Test purified C-terminal fusion proteins under controlled conditions and include concentration, buffer, crowding, and time as variables in follow-up experiments; the reported condensate behavior is a study finding, not a universal formulation.

These parameters describe the logic of the published experiments rather than a turnkey replication protocol. In particular, imaging exposure, construct expression level, oxidative reagent, and in vitro protein concentration can strongly affect apparent condensate formation.

Core Findings and Why They Matter

Stress produces a less mobile nuclear dKeap1 population

The study found that dKeap1 accumulated in the nucleus and progressively formed stable foci after oxidative treatment. FRAP indicated reduced mobility within the foci, supporting the idea that dKeap1 becomes incorporated into a structured or condensed molecular environment. This matters because a less mobile pool could remain associated with chromatin or nuclear scaffolds long enough to influence local transcriptional regulation.

The C-terminal region provides condensate-forming potential

Two intrinsically disordered regions were identified in the dKeap1 C-terminal domain, and C-terminal YFP fusion proteins formed condensates in vitro. IDRs are frequently involved in multivalent protein interactions, so this result provides a plausible molecular basis for dKeap1 assembly. It also offers a tractable system for testing how sequence composition, protein concentration, and binding partners influence condensate properties.

The Kelch domain acts as a restraint

Deletion of the Kelch domain caused robust cytoplasmic foci under basal conditions, and the in vitro experiments supported a suppressive role for this domain. The finding is important because it shows that structured domains can inhibit, not simply promote, condensation. Full-length dKeap1 may therefore remain soluble or properly distributed until stress, localization changes, or partner interactions relieve this restraint.

A possible link to chromatin regulation

The authors place these observations in the context of earlier evidence that dKeap1 binds chromatin and regulates developmental genes. Nuclear condensates could provide a mechanism for concentrating dKeap1 and associated factors at selected genomic regions. Nevertheless, the study does not establish that every visible focus is chromatin-bound or that focus formation directly causes a specific transcriptional outcome. The strongest conclusion is that stress-responsive dKeap1 assembly is a newly defined cellular property that may help explain its nuclear functions.

Comparison with Existing Internal Articles

The internal article on mechanistic precision in protein purification approaches the subject from the perspective of recombinant protein preparation and tag removal. Its relevance here is methodological: isolated dKeap1 domains or fluorescent fusion constructs may require careful preparation before in vitro condensate assays. It does not, however, provide independent evidence for the oxidative-stress mechanism reported in the reference study.

Similarly, the scenario-driven purification guide emphasizes workflow optimization for fusion protein tag cleavage. That practical focus complements, but should not be conflated with, the Drosophila cell biology. The reference study establishes domain-dependent assembly; purification resources address how researchers might obtain appropriately prepared recombinant components for follow-up biochemical experiments.

Limitations and Transferability

Several limitations define how broadly these results should be interpreted. First, the findings come from a Drosophila system. Although the Keap1–Nrf2 pathway is conserved, mammalian Keap1 may differ in domain interactions, nuclear trafficking, expression context, and chromatin partners. Direct transfer to human oxidative-stress biology therefore requires experiments with mammalian proteins and cells.

Second, nuclear foci and in vitro condensates are consistent with biomolecular condensation but do not by themselves prove liquid–liquid phase separation. A complete physical characterization would require systematic analysis of reversibility, concentration dependence, fusion behavior, material properties, and the influence of nucleic acids or binding partners. FRAP provides valuable mobility information, yet slow recovery can also reflect stable complexes or scaffold attachment.

Third, the study identifies domain requirements without fully resolving the molecular contacts that connect the N-terminal domain, C-terminal IDRs, Kelch domain, and nuclear environment. It also does not demonstrate that oxidative stress modifies dKeap1 directly, nor does it define whether condensates activate, repress, or spatially reorganize particular genes. These unanswered questions are important for distinguishing a structural consequence of stress from a functional transcriptional mechanism.

Despite these constraints, the findings are transferable as an experimental framework. Researchers can combine live imaging, FRAP, domain dissection, and purified-protein assays to test whether other stress-regulated nuclear proteins use similarly balanced assembly and restraint mechanisms.

Research Support Resources

Why this cross-domain matters, maturity, and limitations

Protein purification is an enabling step for testing condensate mechanisms, but it is not evidence that a purification enzyme preserves the native behavior of dKeap1. Any bridge from the reference study to recombinant-protein workflows remains at the application stage: tag removal, buffer exchange, protein concentration, and storage can all influence an in vitro assembly assay. Researchers should therefore validate the cleaved protein by comparing purity, oligomeric state, fluorescence behavior, and condensate properties with appropriate controls.

For workflows requiring precise fusion protein tag cleavage, researchers can use PreScission Protease (PSP) (SKU K1101), a recombinant HRV 3C protease–GST fusion and protein purification enzyme. The product information describes recognition of the Leu-Glu-Val-Leu-Phe-Gln-Gly-Pro sequence and cleavage between Gln and Gly, making it relevant to GST fusion protein cleavage when the corresponding prescission protease cleavage site has been engineered into a construct. Its reported low-temperature protease activity may be useful when handling temperature-sensitive recombinant domains, but optimization remains necessary for each condensate assay. The product information recommends storage at −80 °C and aliquoting to limit freeze–thaw exposure.